Media coverage about ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) has been trending somewhat positive on Friday, Accern Sentiment Analysis reports. The research firm rates the sentiment of media coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. ProShares Ultra Nasdaq Biotechnology ETF earned a media sentiment score of 0.11 on Accern’s scale. Accern also gave news headlines about the exchange traded fund an impact score of 48.0577645200704 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Shares of ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ BIB) traded up 0.64% during trading on Friday, reaching $51.53. 181,135 shares of the company were exchanged. ProShares Ultra Nasdaq Biotechnology ETF has a 52-week low of $35.00 and a 52-week high of $60.19. The stock’s 50-day moving average is $55.57 and its 200-day moving average is $49.62.

TRADEMARK VIOLATION NOTICE: “ProShares Ultra Nasdaq Biotechnology ETF (BIB) Earning Somewhat Positive Media Coverage, Study Finds” was originally reported by Watch List News and is the sole property of of Watch List News. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international copyright and trademark laws. The correct version of this report can be viewed at

About ProShares Ultra Nasdaq Biotechnology ETF

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.

Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology ETF and related companies with Analyst Ratings Network's FREE daily email newsletter.